Neonatal treatment of rats with the neuroactive steroid 
tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine 
consequences of adverse early life events

Patchev, V. K.; Montkowski, A.; Rouskova, D.; Koranyi, L.; Holsboer, F.; Almeida, O. F. X.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Neonatal treatment of rats with the neuroactive steroid tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events

MPS-Authors

/persons/resource/persons80372

Holsboer, F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80249

Almeida, O. F. X.
AG Almeida, Osborne, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Patchev, V. K., Montkowski, A., Rouskova, D., Koranyi, L., Holsboer, F., & Almeida, O. F. X. (1997). Neonatal treatment of rats with the neuroactive steroid tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. Journal of Clinical Investigation, 99, 962-966.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-AA20-C

Abstract

There is no abstract available